TRIEU VUONG (CEO and Chairman of the Board) purchased 0.4% of their position (346.84K shares) of ONCOTELIC THERAPEUTICS, INC. on the open market
Open‑market purchase worth $9.7K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 1/31/2025ACC: 0001493152-25-004486
DirectorOfficer10% Owner· CEO and Chairman of the Board
Since Apr 2019
+346.84K
Net shares
Net buyer
$9.7K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
346.84K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+183.07K
Price / share
$0.03
Trade value
$5.13K
% of position
0.2%
1/29/2025
92.84M→93.03M
Common Stock
Direct
Shares
+100K
Price / share
$0.03
Trade value
$2.80K
% of position
0.1%
1/30/2025
93.03M→93.13M
Common Stock
Direct
Shares
+63.77K
Price / share
$0.03
Trade value
$1.79K
% of position
0.1%
1/31/2025
93.13M→93.19M
Total
Net shares
+346.84K
Net value
$9.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2025 | P · Purchase | +183.07K | $0.03 | $5.13K | 0.2% | 92.84M | 93.03M |
| Common Stock Direct | 1/30/2025 | P · Purchase | +100K | $0.03 | $2.80K | 0.1% | 93.03M | 93.13M |
| Common Stock Direct | 1/31/2025 | P · Purchase | +63.77K | $0.03 | $1.79K | 0.1% | 93.13M | 93.19M |
| Total | +346.84K | $9.71K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned16.78M
Common Stock
IndirectShares owned6.87M
Total
23.65M indirect23.65M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 16.78M | Indirect |
| Common Stock | 6.87M | Indirect |
| Total | 23.65M | 23.65M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported